NEW YORK, August 5, 2014 /PRNewswire/ --

BreedIT Corp., (OTCQB: BRDT) through its Israeli subsidiary BreedIT Ltd., the

exclusive worldwide license holder and distributor of iBreedIT(R), a leading

Intelligent

Decision Support System (IDSS) for plant breeders and researchers, is pleased to

announce

the completion of the iBreedIT(R) English interface for the US market. Already widely

used

by breeders in Israel, the Company will launch the product in the US in the fourth

quarter

of 2014.

The proprietary iBreedIT(R) software was developed by the Hebrew University of

Jerusalem and has been instrumental in the development of many of the crops consumed

around the world every day, including the Daniela tomatoes-on-the-vine.

Unlike other breeding protocols that modify the genetic makeup of seeds (GMO) to

develop new plant strains, BreedIT's platform enables researchers to tag the desired

genes

and then nurture the development of seeds with the sought after characteristics.

iBreedIT

also facilitates research and development by enabling breeders to manage and analyze

data

quickly, resulting in improved product quality and reductions in time to market and

development costs.

In July of this year, Dr. Oded Sagee, BreedIT's Ltd Founder and Chief Executive

Officer, and Yoel Yogev, Chairman of the Board, beta-tested the interface with a

selected

group of medical cannabis growers in Denver, Colorado, considered by many to be the

bellwether market for the industry.

Commenting on the US launch, Dr. Sagee stated, "The medicinal cannabis market is a

natural fit for our technology. With millions of dollars at stake, being first to

market

is a real competitive advantage for breeders and developers. However, because the end

product of Medical Cannabis is administered to children and adults, many with serious

health issues, it is critical that this process be managed with care, including proper

testing protocol, comprehensive documentation and uniform plant development. The

iBreedIT

platform was created specifically to provide breeders and researchers with the tools to

achieve those objectives."

Dr. Sagee went on to say, "The trip to Denver confirmed our strategy to pursue the

US

medical cannabis market, where participants face a lot of regulatory scrutiny. Grower

reaction to the iBreedIT platform was extremely positive and we have subsequently begun

negotiations with several potential licensees and research partners."

Dr. Alan Shackelford, BreedIT's Chief Medical Advisor and member of the Scientific

Advisory Board, talked further about opportunities within the medical cannabis market,

saying, "Acknowledgement of cannabis as a valid treatment for a variety of medical

conditions is accelerating as the evidence of its effectiveness mounts. New protocols

and

applications are being investigated every day, often for conditions where traditional

pharmaceuticals have proven ineffective and time is of the essence. The iBreedIT

platform

reduces the time and cost of plant development, and in turn, expedites breeders'

ability

to safely get new cannabis strains to the patients that need them."

About BreedIT Corp.

BreedIT Corp (BRDT [http://finance.yahoo.com/q?s=brdt ]), through its Israeli

subsidiary, BreedIT Ltd http://www.ibreedit.com, is the developer of highly

sophisticated agro-breeding solutions for plant breeders and researchers. BreedIT's

proven

iBreedIT(R) - the Intelligent Decision Support System (IDSS) for breeders which was

developed by a team consisting of among the world's leading breeding specialists for

optimizing the breeding processes, services the plant breeding needs of corporations,

research and government institutions. BreedIT's IDSS provides advanced solutions for

generating and disseminating knowledge aimed at assisting breeders to plan, manage and

analyze their breeding data and to perform research activities quickly and effectively.

Founded in 2010, BreedIT Corp has offices in New York, New York and in Rehovot, Israel.

Forward-Looking Statements:

This press release may contain forward-looking statements, including information

about

management's view of the Company's future expectations, plans and prospects, within the

safe harbor provisions under The Private Securities Litigation Reform Act of 1995 (the

"Act"). In particular, when used in the preceding discussion, the words "believes,"

"expects," "intends," "plans," "anticipates," or "may," and similar conditional

expressions are intended to identify forward-looking statements within the meaning of

the

Act, and are subject to the safe harbor created by the Act. Any statements made in this

news release other than those of historical fact, about an action, event or

development,

are forward-looking statements. These statements involve known and unknown risks,

uncertainties and other factors, which may cause the results of the Company, its

divisions

and concepts to be materially different than those expressed or implied in such

statements. These risk factors and others are included from time to time in documents

the

Company files with the Securities and Exchange Commission, including but not limited

to,

its Form 10-K, Form 10-Qs and Form 8-Ks. Other unknown or unpredictable factors also

could

have material adverse effects on the Company's future results. The forward-looking

statements included in this press release are made only as of the date hereof. The

Company

cannot guarantee future results, levels of activity, performance or achievements.

Accordingly, you should not place undue reliance on these forward-looking statements.

Finally, the Company undertakes no obligation to update these statements after the date

of

this release, except as required by law, and also takes no obligation to update or

correct

information prepared by third parties that are not paid for by the Company. In

evaluating

such statements, prospective investors should review carefully various risks and

uncertainties identified in this release, as actual results may differ materially from

those indicated.*

BreedIt Corp's public filings may be viewed at http://www.sec.gov.

SOURCE BreedIT Corp